Low-titer antibodies reactive with HTLV-I gag P19 in patients with chronic myeloneuropathy
- 1 October 1989
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 26 (4) , 515-522
- https://doi.org/10.1002/ana.410260404
Abstract
To elucidate the possible association of human T-lymphotropic virus type I (HTLV-I) and chronic neurological diseases, 156 serum samples from patients with various neurological diseases, including multiple sclerosis, chronic progressive myelopathy, chronic inflammatory polyradiculoneuropathy, myasthenia gravis, polymyositis, motor neuron disease, and tension headache, and healthy control subjects were examined for IgG antibodies to HTLV-I by three independent techniques–gelatin particle agglutination test, enzyme-linked immunosorbent assay, and Western blot assay. Specificity of antibodies was assessed by homologous competitive inhibition on Western blot assay. Six patients (3 with chronic progressive myelopathy, 1 with chronic inflammatory polyradiculoneropathy, 1 with motor neuron disease, and 1 with tension headache) had high-titer HTLV-I antibodies. Twelve patients (5 with multiple sclerosis, 1 with chronic progressive myelopathy, 2 with chronic inflammatory polyradiculoneuropathy, 2 with myasthenia gravis, and 2 with motor neuron disease) had low-titer HTLV-I antibodies that reached with a single gag protein, p19, or p24, on Western blot assay. In 4 (2 with multiple sclerosis, 1 with chronic progressive myelopathy, and 1 with chronic inflammatory polyradiculoneuropathy) of these 12, the antibodies that were all directed to p19 were determined to be specific by homologous competitive inhibition. In the remaining 8 patients (3 with multiple sclerosis, 1 with chronic inflammatory polyradiculoneuropathy, 2 with myasthenia gravis, 2 with motor neuron disease), restricted reactions against p19 or p24 were considered to be nonspecific because they were not inhibited by homologous competitive inhibition. The results suggest that in some patients chronic myeloneuropathy diagnosed as chronic progressive multiple sclerosis, chronic progressive myelopathy, and chronic inflammatory polyradiculoneuropathy may be associated with HTLV-I or related retroviruses.This publication has 55 references indexed in Scilit:
- Detection of Human T-Cell Lymphoma/Leukemia Virus Type I DNA and Antigen in Spinal Fluid and Blood of Patients with Chronic Progressive MyelopathyNew England Journal of Medicine, 1988
- Interpretation of Antibodies Reacting Solely with Human Retroviral Core ProteinsNew England Journal of Medicine, 1988
- HTLV-I-associated leukemia: A model for chronic retroviral diseasesAnnals of Neurology, 1988
- INTERPRETATION OF ISOLATED HIV ANTI-p24 REACTIVITY IN WESTERN BLOT ANALYSISThe Lancet, 1987
- Multiple sclerosis and human T-cell lymphotropic retrovirusesNature, 1985
- Chronic encephalomyelitis presenting as chronic progressive myelopathy.Journal of Neurology, Neurosurgery & Psychiatry, 1984
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- Effect of adult T-cell leukemia cells on pokeweed mitogen-induced normal B-cell differentiationClinical Immunology and Immunopathology, 1978
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970